La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Schizophrenia »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Scattering, Small Angle < Schizophrenia < Schizophrenia, Paranoid  Facettes :

List of bibliographic references indexed by Schizophrenia

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
001267 (2012) Pierre J. Blanchet [Canada] ; Louise Normandeau ; Pierre H. RompréComparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot study.
001584 (2011) Jesse Gillis [Canada] ; Paul Pavlidis [Canada]The Impact of Multifunctional Genes on "Guilt by Association" Analysis
001597 (2011) Gary Remington [Canada] ; Ofer Agid ; George FoussiasSchizophrenia as a disorder of too little dopamine: implications for symptoms and treatment.
001598 (2011) Amin GaditSchizophrenia and Parkinson’s disease: challenges in management
001973 (2010) Dominic Thibault [Canada] ; Christian Kortleven ; Caroline Fasano ; Gregory Dal Bo ; Louis-Eric Trudeau[Recent discoveries on the function and plasticity of central dopamine pathways].
002148 (2008) Leonardo Cortese [Canada] ; Michael P. Caligiuri ; Richard Williams ; Peter Schieldrop ; Rahul Manchanda ; Ashok Malla ; Raj HarricharanReduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
002962 (2005) Leonardo Cortese [Canada] ; Michael P. Caligiuri ; Ashok K. Malla ; Rahul Manchanda ; Jatinder Takhar ; Raj HaricharanRelationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients.
002981 (2005) William G. Honer [Canada] ; Lili C. Kopala ; Jonathan RabinowitzExtrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
002F82 (2002) Philip Seeman [Canada]Atypical antipsychotics: mechanism of action.
003588 (2000) M. Cyr [Canada] ; F. Calon [Canada] ; M. Morissette [Canada] ; M. Grandbois [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada]Drugs with estrogen-like potency and brain activity : Potential therapeutic application for the CNS
003A66 (1997) L A Tugg [Canada] ; D. Desai ; P. Prendergast ; G. Remington ; K. Reed ; R B ZipurskyRelationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.
003D00 (1996) T V Beischlag [Canada] ; D. Nam ; C. Ulpian ; P. Seeman ; H B NiznikA polymorphic dinucleotide repeat in the human dopamine D5 receptor gene promoter.
003F07 (1996) M. D. Berry [Canada] ; A. V. Juorio [Canada] ; X.-M. Li [Canada] ; A. A. Boulton [Canada]Aromatic L-amino acid decarboxylase : A neglected and misunderstood enzyme
004157 (1994) M. D. Berry [Canada] ; A. V. Juorio [Canada] ; I. A. Paterson [Canada]Possible mechanisms of action of (−)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders
004315 (1993) P. Seeman [Canada] ; H H Van TolDopamine receptor pharmacology.
004392 (1993) Philip Seeman [Canada] ; Hong-Chang Guan [Canada] ; Hubert H. M. Van Tol [Canada] ; Hyman B. Niznik [Canada]Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata
004855 (1990) P. Seeman [Canada] ; H B NiznikDopamine receptors and transporters in Parkinson's disease and schizophrenia.
004861 (1990) C. Clark ; R. Marbeck ; D. LiAn empirical model for analysing and interpreting ventricular measures.
004999 (1990) R. K. B. Pearce ; P. Seeman ; K. Jellinger ; W. W. TourtelotteDopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia
004A14 (1989) P. Seeman ; H B Niznik ; H C Guan ; G. Booth ; C. UlpianLink between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
004B44 (1988) G. Chouinard [Canada]The use of benzodiazepines in the treatment of manic-depressive illness.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Schizophrenia" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Schizophrenia" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Schizophrenia
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022